Zobrazeno 1 - 10
of 102
pro vyhledávání: '"H H Balfour"'
Autor:
J. Zhou, D. Doueck, R. R. Ladi, Bharat Madan, Jacy R. Wolfe, N. Boyle, C. Yu Chung, David Price, S. N. Lopez Acevedo, Sian Llewellyn-Lacey, Rodrigo Matus-Nicodemos, A. S. Fahad, Amy D. Laflin, H. H. Balfour, Brandon J. DeKosky, Matias Gutiérrez-González
Functional analyses of the T cell receptor (TCR) landscape can reveal critical information about protection from disease and molecular responses to vaccines. However, it has proven difficult to combine advanced next-generation sequencing technologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a0112137bee9700696c19aab0e78ec5
https://doi.org/10.1101/2021.10.19.465057
https://doi.org/10.1101/2021.10.19.465057
Publikováno v:
The Journal of Immunology. 149:676-680
Cocaine and CMV each have been suggested to promote the progression of HIV-1 infection. In the present study, the interaction of cocaine and CMV was investigated in a PBMC coculture assay in which release of HIV-1 p24 Ag into coculture supernatants w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2c0dfd7ef276ab8687a1db277b3e4ed
https://doi.org/10.4049/jimmunol.149.2.676
https://doi.org/10.4049/jimmunol.149.2.676
Publikováno v:
The Journal of Immunology. 146:81-84
Cocaine use is an important high risk behavior in the AIDS epidemic. In this study, we tested the hypothesis that cocaine potentiates the replication of HIV-1 in human PBMC. A coculture system was used in which PBMC from healthy donors were incubated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89de4a6793743b54317e893bce3e625f
https://doi.org/10.4049/jimmunol.146.1.81
https://doi.org/10.4049/jimmunol.146.1.81
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 4(4)
A 20-year-old patient, who received a bone marrow transplant in order to treat metachromatic leukodystrophy (MLD), succumbed to cytomegalovirus (CMV) encephalitis. After CMV viremia developed, the patient received ganciclovir, but he was switched to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::873b399ae8799c0e4f46722e4812e217
https://pubmed.ncbi.nlm.nih.gov/12535263
https://pubmed.ncbi.nlm.nih.gov/12535263
Autor:
W M, El-Sadr, R L, Murphy, T M, Yurik, R, Luskin-Hawk, T W, Cheung, H H, Balfour, R, Eng, T M, Hooton, T M, Kerkering, M, Schutz, C, van der Horst, R, Hafner
Publikováno v:
The New England journal of medicine. 339(26)
Although trimethoprim-sulfamethoxazole is the drug of choice for the prevention of Pneumocystis carinii pneumonia, many patients cannot tolerate it and must switch to an alternative agent.We conducted a multicenter, open-label, randomized trial compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f09b7f0d222b29af734c5bd9bf584fa
https://pubmed.ncbi.nlm.nih.gov/10328722
https://pubmed.ncbi.nlm.nih.gov/10328722
Autor:
K, Henry, A, Erice, C, Tierney, H H, Balfour, M A, Fischl, A, Kmack, S H, Liou, A, Kenton, M S, Hirsch, J, Phair, A, Martinez, J O, Kahn
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 19(4)
The primary objective was to compare the effects of dual or triple combinations of HIV-1 reverse transcriptase inhibitors with respect to survival. The time to new HIV disease progression or death, toxicities, the change in CD4 cells, and plasma HIV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da0969ee6c4e53a4f5921a9fbd7c94d3
https://pubmed.ncbi.nlm.nih.gov/9833742
https://pubmed.ncbi.nlm.nih.gov/9833742
Autor:
S M, Hammer, K E, Squires, M D, Hughes, J M, Grimes, L M, Demeter, J S, Currier, J J, Eron, J E, Feinberg, H H, Balfour, L R, Deyton, J A, Chodakewitz, M A, Fischl
Publikováno v:
The New England journal of medicine. 337(11)
The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We compared treatment with the protease inhibitor indinavir in addition to zidovudine and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::570500dde96a63573089c18d9bdc8b75
https://pubmed.ncbi.nlm.nih.gov/9441226
https://pubmed.ncbi.nlm.nih.gov/9441226
Publikováno v:
Pharmacotherapy. 17(3)
To evaluate the pharmacokinetics, safety, and feasibility of concentration-controlled oral zidovudine therapy.Randomized, crossover, open-label study.University-affiliated general clinical research center.Eight individuals infected with the human imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eaef174e2b76cae54ab8dcee7ee50085
https://pubmed.ncbi.nlm.nih.gov/9165546
https://pubmed.ncbi.nlm.nih.gov/9165546
Autor:
H H, Balfour
Publikováno v:
Presse medicale (Paris, France : 1983). 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c04e0f8bea79f510a6c021ee94e99f5c
https://pubmed.ncbi.nlm.nih.gov/9082438
https://pubmed.ncbi.nlm.nih.gov/9082438
Autor:
C V, Fletcher, H H, Balfour
Publikováno v:
Pharmacotherapy. 16(6)
This study explored the variability of zidovudine concentrations with computer simulations and measured concentrations. A one-compartment oral absorption model was selected to characterize zidovudine disposition. Mean (+/-standard deviation) values f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f337513cd58572885af846c97cd2cae2
https://pubmed.ncbi.nlm.nih.gov/8947989
https://pubmed.ncbi.nlm.nih.gov/8947989